Literature DB >> 18707841

Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.

Naureen J Iqbal1, Angeline Boey, Benjamin J Park, Mary E Brandt.   

Abstract

We evaluated the susceptibility of 85 Fusarium spp. isolates from cases of fungal keratitis with 8 antifungal drugs using the standard Clinical and Laboratory Standards Institute broth microdilution and E test methods. Members of the Fusarium solani species complex showed consistently higher MICs to the triazole drugs itraconazole, voriconazole, and posaconazole than did members of other species complexes (Fusarium oxysporum and other minor species). High MICs to amphotericin B, natamycin, and echinocandins were consistently obtained with no discrimination based on species or method. Further work is required to determine any potential correlation between MIC and clinical outcome in keratitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18707841     DOI: 10.1016/j.diagmicrobio.2008.07.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  13 in total

1.  Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

Authors:  A Debourgogne; S de Hoog; A Lozniewski; M Machouart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-09       Impact factor: 3.267

2.  Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.

Authors:  David Triest; Dirk Stubbe; Koen De Cremer; Denis Piérard; Anne-Cécile Normand; Renaud Piarroux; Monique Detandt; Marijke Hendrickx
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

3.  International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors:  Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

4.  Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Authors:  Abdullah M S Al-Hatmi; Anne-Cécile Normand; Stephane Ranque; Renaud Piarroux; G Sybren de Hoog; Joseph Meletiadis; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 5.  Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.

Authors:  R Araujo; M Oliveira; A Amorim; B Sampaio-Maia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-18       Impact factor: 3.267

6.  Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.

Authors:  Vladimír Buchta; Alena Feuermannová; Martin Váša; Lenka Bašková; Radka Kutová; Alena Kubátová; Marcela Vejsová
Journal:  Mycopathologia       Date:  2014-01-01       Impact factor: 2.574

7.  European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.

Authors:  A M Tortorano; A Prigitano; M C Esposto; V Arsic Arsenijevic; J Kolarovic; D Ivanovic; L Paripovic; L Klingspor; I Nordøy; P Hamal; S Arikan Akdagli; C Ossi; A Grancini; C Cavanna; G Lo Cascio; C Scarparo; A Candoni; M Caira; M Drogari Apiranthitou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

8.  Fusarium Keratitis in Germany.

Authors:  Grit Walther; Serena Stasch; Kerstin Kaerger; Axel Hamprecht; Mathias Roth; Oliver A Cornely; Gerd Geerling; Colin R Mackenzie; Oliver Kurzai; Marie von Lilienfeld-Toal
Journal:  J Clin Microbiol       Date:  2017-07-26       Impact factor: 5.948

9.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

10.  Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes.

Authors:  Rafael A Oechsler; Michael R Feilmeier; Darlene Miller; Wei Shi; Ana Luisa Hofling-Lima; Eduardo C Alfonso
Journal:  Cornea       Date:  2013-05       Impact factor: 2.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.